AN2 Therapeutics posts updated investor presentation with no new material facts

AN2 Therapeutics, Inc.

Filed 8-K under Item 7.01 furnishing an updated investor presentation dated June 2025.
No specific financial results, pipeline updates, or guidance changes disclosed in the filing.
Presentation available on the 'Investors' section of the company's website.
No material information beyond the routine investor update was provided.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.